Position in TGTX
as of Mar 31, 2026
· filed May 22, 2026
Position Value
$6,119,024
+$381,971 QoQ
Shares Held
184,197
-4.3% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SEGALL BRYANT & HAMILL, LLC holds $242,312,554 across 27 Biotechnology names. TGTX ranks #16 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
212,714 | $22,420,055 | |
| 2 | TECH |
BIO-TECHNE Corp
|
428,507 | $22,393,775 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
79,497 | $20,535,665 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
298,056 | $19,263,359 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
38,073 | $17,001,117 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
31,870 | $16,682,988 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
175,898 | $16,249,457 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
195,380 | $13,311,239 |
All Filings in TGTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,119,024 | 184,197 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $5,737,053 | 192,454 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,811,717 | 77,833 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,816,937 | 78,270 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,370,121 | 85,471 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,393,491 | 79,518 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,225,402 | 52,390 | Shares | Sole | 2024-11-08 | |
| 2021-03-31 | $241,000 | 5,000 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $260,100 | 5,000 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||